0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Immunology-Oncology Elisa Kits Market Research Report 2026
Published Date: 2026-01-30
|
Report Code: QYRE-Auto-17S18676
Home | Market Reports
Global Immunology Oncology Elisa Kits Market Research Report 2024
BUY CHAPTERS

Global Immunology-Oncology Elisa Kits Market Research Report 2026

Code: QYRE-Auto-17S18676
Report
2026-01-30
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Immunology-Oncology Elisa Kits Market

The global Immunology-Oncology Elisa Kits market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Immunology-Oncology Elisa Kits competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Immunology-Oncology ELISA kits are laboratory tools used for the detection and quantification of specific proteins, antibodies, or biomarkers related to cancer (oncology) and immune system responses (immunology). These kits utilize the Enzyme-Linked Immunosorbent Assay (ELISA) technique, which is a highly sensitive and specific method used in immunology and cancer research to detect molecules like cytokines, tumor markers, or immune checkpoints. The kits are essential in diagnostics, research, and therapeutic development in oncology and immunology fields.
The North American market for Immunology-Oncology Elisa Kits is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Immunology-Oncology Elisa Kits is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Immunology-Oncology Elisa Kits include Thermo Fisher Scientific, Bio-Techne Corporation (R&D Systems), Abcam, BioLegend (part of PerkinElmer), BD Biosciences, MilliporeSigma (Merck KGaA), Enzo Life Sciences, RayBiotech Life, Inc., ELISAGEN Biotech, Creative Diagnostics, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Immunology-Oncology Elisa Kits market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Immunology-Oncology Elisa Kits. The Immunology-Oncology Elisa Kits market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Immunology-Oncology Elisa Kits market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Immunology-Oncology Elisa Kits manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Immunology-Oncology Elisa Kits Market Report

Report Metric Details
Report Name Immunology-Oncology Elisa Kits Market
Segment by Type
  • Direct ELISA Kit
  • Indirect ELISA Kit
by Application
  • Cancer Diagnosis
  • Pharmaceutical Industry
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Thermo Fisher Scientific, Bio-Techne Corporation (R&D Systems), Abcam, BioLegend (part of PerkinElmer), BD Biosciences, MilliporeSigma (Merck KGaA), Enzo Life Sciences, RayBiotech Life, Inc., ELISAGEN Biotech, Creative Diagnostics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Immunology-Oncology Elisa Kits manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Immunology-Oncology Elisa Kits sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

Who are the main players in the Immunology-Oncology Elisa Kits Market report?

Ans: The main players in the Immunology-Oncology Elisa Kits Market are Thermo Fisher Scientific, Bio-Techne Corporation (R&D Systems), Abcam, BioLegend (part of PerkinElmer), BD Biosciences, MilliporeSigma (Merck KGaA), Enzo Life Sciences, RayBiotech Life, Inc., ELISAGEN Biotech, Creative Diagnostics

What are the Application segmentation covered in the Immunology-Oncology Elisa Kits Market report?

Ans: The Applications covered in the Immunology-Oncology Elisa Kits Market report are Cancer Diagnosis, Pharmaceutical Industry, Other

What are the Type segmentation covered in the Immunology-Oncology Elisa Kits Market report?

Ans: The Types covered in the Immunology-Oncology Elisa Kits Market report are Direct ELISA Kit, Indirect ELISA Kit

1 Immunology-Oncology Elisa Kits Market Overview
1.1 Product Definition
1.2 Immunology-Oncology Elisa Kits by Type
1.2.1 Global Immunology-Oncology Elisa Kits Market Value by Type: 2025 vs 2032
1.2.2 Direct ELISA Kit
1.2.3 Indirect ELISA Kit
1.3 Immunology-Oncology Elisa Kits by Application
1.3.1 Global Immunology-Oncology Elisa Kits Market Value by Application: 2025 vs 2032
1.3.2 Cancer Diagnosis
1.3.3 Pharmaceutical Industry
1.3.4 Other
1.4 Global Immunology-Oncology Elisa Kits Market Size Estimates and Forecasts
1.4.1 Global Immunology-Oncology Elisa Kits Revenue 2021–2032
1.4.2 Global Immunology-Oncology Elisa Kits Sales 2021–2032
1.4.3 Global Immunology-Oncology Elisa Kits Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Immunology-Oncology Elisa Kits Market Competition by Manufacturers
2.1 Global Immunology-Oncology Elisa Kits Sales Market Share by Manufacturers (2021–2026)
2.2 Global Immunology-Oncology Elisa Kits Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Immunology-Oncology Elisa Kits Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Immunology-Oncology Elisa Kits, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Immunology-Oncology Elisa Kits, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Immunology-Oncology Elisa Kits, Product Types and Applications
2.7 Global Key Manufacturers of Immunology-Oncology Elisa Kits, Date of Entry into the Industry
2.8 Global Immunology-Oncology Elisa Kits Market Competitive Situation and Trends
2.8.1 Global Immunology-Oncology Elisa Kits Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Immunology-Oncology Elisa Kits Players Market Share by Revenue
2.8.3 Global Immunology-Oncology Elisa Kits Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Immunology-Oncology Elisa Kits Market Scenario by Region
3.1 Global Immunology-Oncology Elisa Kits Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Immunology-Oncology Elisa Kits Sales by Region: 2021–2032
3.2.1 Global Immunology-Oncology Elisa Kits Sales by Region: 2021–2026
3.2.2 Global Immunology-Oncology Elisa Kits Sales by Region: 2027–2032
3.3 Global Immunology-Oncology Elisa Kits Revenue by Region: 2021–2032
3.3.1 Global Immunology-Oncology Elisa Kits Revenue by Region: 2021–2026
3.3.2 Global Immunology-Oncology Elisa Kits Revenue by Region: 2027–2032
3.4 North America Immunology-Oncology Elisa Kits Market Facts & Figures by Country
3.4.1 North America Immunology-Oncology Elisa Kits Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Immunology-Oncology Elisa Kits Sales by Country (2021–2032)
3.4.3 North America Immunology-Oncology Elisa Kits Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Immunology-Oncology Elisa Kits Market Facts & Figures by Country
3.5.1 Europe Immunology-Oncology Elisa Kits Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Immunology-Oncology Elisa Kits Sales by Country (2021–2032)
3.5.3 Europe Immunology-Oncology Elisa Kits Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Immunology-Oncology Elisa Kits Market Facts & Figures by Region
3.6.1 Asia Pacific Immunology-Oncology Elisa Kits Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Immunology-Oncology Elisa Kits Sales by Region (2021–2032)
3.6.3 Asia Pacific Immunology-Oncology Elisa Kits Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Immunology-Oncology Elisa Kits Market Facts & Figures by Country
3.7.1 Latin America Immunology-Oncology Elisa Kits Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Immunology-Oncology Elisa Kits Sales by Country (2021–2032)
3.7.3 Latin America Immunology-Oncology Elisa Kits Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Immunology-Oncology Elisa Kits Market Facts & Figures by Country
3.8.1 Middle East and Africa Immunology-Oncology Elisa Kits Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Immunology-Oncology Elisa Kits Sales by Country (2021–2032)
3.8.3 Middle East and Africa Immunology-Oncology Elisa Kits Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Immunology-Oncology Elisa Kits Sales by Type (2021–2032)
4.1.1 Global Immunology-Oncology Elisa Kits Sales by Type (2021–2026)
4.1.2 Global Immunology-Oncology Elisa Kits Sales by Type (2027–2032)
4.1.3 Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2021–2032)
4.2 Global Immunology-Oncology Elisa Kits Revenue by Type (2021–2032)
4.2.1 Global Immunology-Oncology Elisa Kits Revenue by Type (2021–2026)
4.2.2 Global Immunology-Oncology Elisa Kits Revenue by Type (2027–2032)
4.2.3 Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2021–2032)
4.3 Global Immunology-Oncology Elisa Kits Price by Type (2021–2032)
5 Segment by Application
5.1 Global Immunology-Oncology Elisa Kits Sales by Application (2021–2032)
5.1.1 Global Immunology-Oncology Elisa Kits Sales by Application (2021–2026)
5.1.2 Global Immunology-Oncology Elisa Kits Sales by Application (2027–2032)
5.1.3 Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2021–2032)
5.2 Global Immunology-Oncology Elisa Kits Revenue by Application (2021–2032)
5.2.1 Global Immunology-Oncology Elisa Kits Revenue by Application (2021–2026)
5.2.2 Global Immunology-Oncology Elisa Kits Revenue by Application (2027–2032)
5.2.3 Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2021–2032)
5.3 Global Immunology-Oncology Elisa Kits Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Thermo Fisher Scientific
6.1.1 Thermo Fisher Scientific Company Information
6.1.2 Thermo Fisher Scientific Description and Business Overview
6.1.3 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Thermo Fisher Scientific Immunology-Oncology Elisa Kits Product Portfolio
6.1.5 Thermo Fisher Scientific Recent Developments/Updates
6.2 Bio-Techne Corporation (R&D Systems)
6.2.1 Bio-Techne Corporation (R&D Systems) Company Information
6.2.2 Bio-Techne Corporation (R&D Systems) Description and Business Overview
6.2.3 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Product Portfolio
6.2.5 Bio-Techne Corporation (R&D Systems) Recent Developments/Updates
6.3 Abcam
6.3.1 Abcam Company Information
6.3.2 Abcam Description and Business Overview
6.3.3 Abcam Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Abcam Immunology-Oncology Elisa Kits Product Portfolio
6.3.5 Abcam Recent Developments/Updates
6.4 BioLegend (part of PerkinElmer)
6.4.1 BioLegend (part of PerkinElmer) Company Information
6.4.2 BioLegend (part of PerkinElmer) Description and Business Overview
6.4.3 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Product Portfolio
6.4.5 BioLegend (part of PerkinElmer) Recent Developments/Updates
6.5 BD Biosciences
6.5.1 BD Biosciences Company Information
6.5.2 BD Biosciences Description and Business Overview
6.5.3 BD Biosciences Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 BD Biosciences Immunology-Oncology Elisa Kits Product Portfolio
6.5.5 BD Biosciences Recent Developments/Updates
6.6 MilliporeSigma (Merck KGaA)
6.6.1 MilliporeSigma (Merck KGaA) Company Information
6.6.2 MilliporeSigma (Merck KGaA) Description and Business Overview
6.6.3 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Product Portfolio
6.6.5 MilliporeSigma (Merck KGaA) Recent Developments/Updates
6.7 Enzo Life Sciences
6.7.1 Enzo Life Sciences Company Information
6.7.2 Enzo Life Sciences Description and Business Overview
6.7.3 Enzo Life Sciences Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Enzo Life Sciences Immunology-Oncology Elisa Kits Product Portfolio
6.7.5 Enzo Life Sciences Recent Developments/Updates
6.8 RayBiotech Life, Inc.
6.8.1 RayBiotech Life, Inc. Company Information
6.8.2 RayBiotech Life, Inc. Description and Business Overview
6.8.3 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Product Portfolio
6.8.5 RayBiotech Life, Inc. Recent Developments/Updates
6.9 ELISAGEN Biotech
6.9.1 ELISAGEN Biotech Company Information
6.9.2 ELISAGEN Biotech Description and Business Overview
6.9.3 ELISAGEN Biotech Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 ELISAGEN Biotech Immunology-Oncology Elisa Kits Product Portfolio
6.9.5 ELISAGEN Biotech Recent Developments/Updates
6.10 Creative Diagnostics
6.10.1 Creative Diagnostics Company Information
6.10.2 Creative Diagnostics Description and Business Overview
6.10.3 Creative Diagnostics Immunology-Oncology Elisa Kits Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Creative Diagnostics Immunology-Oncology Elisa Kits Product Portfolio
6.10.5 Creative Diagnostics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Immunology-Oncology Elisa Kits Industry Chain Analysis
7.2 Immunology-Oncology Elisa Kits Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Immunology-Oncology Elisa Kits Production Mode & Process Analysis
7.4 Immunology-Oncology Elisa Kits Sales and Marketing
7.4.1 Immunology-Oncology Elisa Kits Sales Channels
7.4.2 Immunology-Oncology Elisa Kits Distributors
7.5 Immunology-Oncology Elisa Kits Customer Analysis
8 Immunology-Oncology Elisa Kits Market Dynamics
8.1 Immunology-Oncology Elisa Kits Industry Trends
8.2 Immunology-Oncology Elisa Kits Market Drivers
8.3 Immunology-Oncology Elisa Kits Market Challenges
8.4 Immunology-Oncology Elisa Kits Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Immunology-Oncology Elisa Kits Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Immunology-Oncology Elisa Kits Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Immunology-Oncology Elisa Kits Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Immunology-Oncology Elisa Kits Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Immunology-Oncology Elisa Kits Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Immunology-Oncology Elisa Kits Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Immunology-Oncology Elisa Kits Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Immunology-Oncology Elisa Kits Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Immunology-Oncology Elisa Kits, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Immunology-Oncology Elisa Kits, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Immunology-Oncology Elisa Kits, Product Types and Applications
 Table 12. Global Key Manufacturers of Immunology-Oncology Elisa Kits, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Immunology-Oncology Elisa Kits Companies by Tier (Tier 1, Tier 2, Tier 3), based on Immunology-Oncology Elisa Kits Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Immunology-Oncology Elisa Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Immunology-Oncology Elisa Kits Sales by Region (K Units), 2021–2026
 Table 18. Global Immunology-Oncology Elisa Kits Sales Market Share by Region (2021–2026)
 Table 19. Global Immunology-Oncology Elisa Kits Sales by Region (K Units), 2027–2032
 Table 20. Global Immunology-Oncology Elisa Kits Sales Market Share by Region (2027–2032)
 Table 21. Global Immunology-Oncology Elisa Kits Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Immunology-Oncology Elisa Kits Revenue Market Share by Region (2021–2026)
 Table 23. Global Immunology-Oncology Elisa Kits Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Immunology-Oncology Elisa Kits Revenue Market Share by Region (2027–2032)
 Table 25. North America Immunology-Oncology Elisa Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Immunology-Oncology Elisa Kits Sales by Country (K Units), 2021–2026
 Table 27. North America Immunology-Oncology Elisa Kits Sales by Country (K Units), 2027–2032
 Table 28. North America Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Immunology-Oncology Elisa Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Immunology-Oncology Elisa Kits Sales by Country (K Units), 2021–2026
 Table 32. Europe Immunology-Oncology Elisa Kits Sales by Country (K Units), 2027–2032
 Table 33. Europe Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Immunology-Oncology Elisa Kits Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Immunology-Oncology Elisa Kits Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Immunology-Oncology Elisa Kits Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Immunology-Oncology Elisa Kits Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Immunology-Oncology Elisa Kits Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Immunology-Oncology Elisa Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Immunology-Oncology Elisa Kits Sales by Country (K Units), 2021–2026
 Table 42. Latin America Immunology-Oncology Elisa Kits Sales by Country (K Units), 2027–2032
 Table 43. Latin America Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Immunology-Oncology Elisa Kits Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Immunology-Oncology Elisa Kits Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Immunology-Oncology Elisa Kits Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Immunology-Oncology Elisa Kits Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Immunology-Oncology Elisa Kits Sales (K Units) by Type (2021–2026)
 Table 51. Global Immunology-Oncology Elisa Kits Sales (K Units) by Type (2027–2032)
 Table 52. Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2021–2026)
 Table 53. Global Immunology-Oncology Elisa Kits Sales Market Share by Type (2027–2032)
 Table 54. Global Immunology-Oncology Elisa Kits Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Immunology-Oncology Elisa Kits Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2021–2026)
 Table 57. Global Immunology-Oncology Elisa Kits Revenue Market Share by Type (2027–2032)
 Table 58. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Immunology-Oncology Elisa Kits Sales (K Units) by Application (2021–2026)
 Table 61. Global Immunology-Oncology Elisa Kits Sales (K Units) by Application (2027–2032)
 Table 62. Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2021–2026)
 Table 63. Global Immunology-Oncology Elisa Kits Sales Market Share by Application (2027–2032)
 Table 64. Global Immunology-Oncology Elisa Kits Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Immunology-Oncology Elisa Kits Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2021–2026)
 Table 67. Global Immunology-Oncology Elisa Kits Revenue Market Share by Application (2027–2032)
 Table 68. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Application (2027–2032)
 Table 70. Thermo Fisher Scientific Company Information
 Table 71. Thermo Fisher Scientific Description and Business Overview
 Table 72. Thermo Fisher Scientific Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Thermo Fisher Scientific Immunology-Oncology Elisa Kits Product
 Table 74. Thermo Fisher Scientific Recent Developments/Updates
 Table 75. Bio-Techne Corporation (R&D Systems) Company Information
 Table 76. Bio-Techne Corporation (R&D Systems) Description and Business Overview
 Table 77. Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Bio-Techne Corporation (R&D Systems) Immunology-Oncology Elisa Kits Product
 Table 79. Bio-Techne Corporation (R&D Systems) Recent Developments/Updates
 Table 80. Abcam Company Information
 Table 81. Abcam Description and Business Overview
 Table 82. Abcam Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Abcam Immunology-Oncology Elisa Kits Product
 Table 84. Abcam Recent Developments/Updates
 Table 85. BioLegend (part of PerkinElmer) Company Information
 Table 86. BioLegend (part of PerkinElmer) Description and Business Overview
 Table 87. BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. BioLegend (part of PerkinElmer) Immunology-Oncology Elisa Kits Product
 Table 89. BioLegend (part of PerkinElmer) Recent Developments/Updates
 Table 90. BD Biosciences Company Information
 Table 91. BD Biosciences Description and Business Overview
 Table 92. BD Biosciences Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. BD Biosciences Immunology-Oncology Elisa Kits Product
 Table 94. BD Biosciences Recent Developments/Updates
 Table 95. MilliporeSigma (Merck KGaA) Company Information
 Table 96. MilliporeSigma (Merck KGaA) Description and Business Overview
 Table 97. MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. MilliporeSigma (Merck KGaA) Immunology-Oncology Elisa Kits Product
 Table 99. MilliporeSigma (Merck KGaA) Recent Developments/Updates
 Table 100. Enzo Life Sciences Company Information
 Table 101. Enzo Life Sciences Description and Business Overview
 Table 102. Enzo Life Sciences Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Enzo Life Sciences Immunology-Oncology Elisa Kits Product
 Table 104. Enzo Life Sciences Recent Developments/Updates
 Table 105. RayBiotech Life, Inc. Company Information
 Table 106. RayBiotech Life, Inc. Description and Business Overview
 Table 107. RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. RayBiotech Life, Inc. Immunology-Oncology Elisa Kits Product
 Table 109. RayBiotech Life, Inc. Recent Developments/Updates
 Table 110. ELISAGEN Biotech Company Information
 Table 111. ELISAGEN Biotech Description and Business Overview
 Table 112. ELISAGEN Biotech Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. ELISAGEN Biotech Immunology-Oncology Elisa Kits Product
 Table 114. ELISAGEN Biotech Recent Developments/Updates
 Table 115. Creative Diagnostics Company Information
 Table 116. Creative Diagnostics Description and Business Overview
 Table 117. Creative Diagnostics Immunology-Oncology Elisa Kits Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Creative Diagnostics Immunology-Oncology Elisa Kits Product
 Table 119. Creative Diagnostics Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Immunology-Oncology Elisa Kits Distributors List
 Table 123. Immunology-Oncology Elisa Kits Customers List
 Table 124. Immunology-Oncology Elisa Kits Market Trends
 Table 125. Immunology-Oncology Elisa Kits Market Drivers
 Table 126. Immunology-Oncology Elisa Kits Market Challenges
 Table 127. Immunology-Oncology Elisa Kits Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Immunology-Oncology Elisa Kits
 Figure 2. Global Immunology-Oncology Elisa Kits Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Immunology-Oncology Elisa Kits Market Share by Type: 2025 & 2032
 Figure 4. Direct ELISA Kit Product Picture
 Figure 5. Indirect ELISA Kit Product Picture
 Figure 6. Global Immunology-Oncology Elisa Kits Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global Immunology-Oncology Elisa Kits Market Share by Application: 2025 & 2032
 Figure 8. Cancer Diagnosis
 Figure 9. Pharmaceutical Industry
 Figure 10. Other
 Figure 11. Global Immunology-Oncology Elisa Kits Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 12. Global Immunology-Oncology Elisa Kits Market Size (US$ Million), 2021–2032
 Figure 13. Global Immunology-Oncology Elisa Kits Sales (K Units), 2021–2032
 Figure 14. Global Immunology-Oncology Elisa Kits Average Price (US$/Unit), 2021–2032
 Figure 15. Immunology-Oncology Elisa Kits Report Years Considered
 Figure 16. Immunology-Oncology Elisa Kits Sales Share by Manufacturers in 2025
 Figure 17. Global Immunology-Oncology Elisa Kits Revenue Share by Manufacturers in 2025
 Figure 18. Top 5 and Top 10 Global Immunology-Oncology Elisa Kits Players: Market Share by Revenue in Immunology-Oncology Elisa Kits in 2025
 Figure 19. Immunology-Oncology Elisa Kits Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 20. Global Immunology-Oncology Elisa Kits Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 21. North America Immunology-Oncology Elisa Kits Sales Market Share by Country (2021–2032)
 Figure 22. North America Immunology-Oncology Elisa Kits Revenue Market Share by Country (2021–2032)
 Figure 23. United States Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 24. Canada Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Europe Immunology-Oncology Elisa Kits Sales Market Share by Country (2021–2032)
 Figure 26. Europe Immunology-Oncology Elisa Kits Revenue Market Share by Country (2021–2032)
 Figure 27. Germany Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. France Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. U.K. Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. Italy Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Russia Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Asia Pacific Immunology-Oncology Elisa Kits Sales Market Share by Region (2021–2032)
 Figure 33. Asia Pacific Immunology-Oncology Elisa Kits Revenue Market Share by Region (2021–2032)
 Figure 34. China Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Japan Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. South Korea Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. India Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Australia Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. China Taiwan Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. Southeast Asia Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Latin America Immunology-Oncology Elisa Kits Sales Market Share by Country (2021–2032)
 Figure 42. Latin America Immunology-Oncology Elisa Kits Revenue Market Share by Country (2021–2032)
 Figure 43. Mexico Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Brazil Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Argentina Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Colombia Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa Immunology-Oncology Elisa Kits Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa Immunology-Oncology Elisa Kits Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE Immunology-Oncology Elisa Kits Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of Immunology-Oncology Elisa Kits by Type (2021–2032)
 Figure 53. Global Revenue Market Share of Immunology-Oncology Elisa Kits by Type (2021–2032)
 Figure 54. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of Immunology-Oncology Elisa Kits by Application (2021–2032)
 Figure 56. Global Revenue Market Share of Immunology-Oncology Elisa Kits by Application (2021–2032)
 Figure 57. Global Immunology-Oncology Elisa Kits Price (US$/Unit) by Application (2021–2032)
 Figure 58. Immunology-Oncology Elisa Kits Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension